Premature promises about cell therapies create expectations ripe for disappointment
Can unproven therapies spoil the sector’s sweet success?
How to spur technological advancements in pharma
Companies that manufacture, sell or dispense drugs in the European Union have until February 9, 2019 to comply. Where does the industry stand?